PRAJ:XETRA:XETRA-Amundi Index Solutions - Amundi Prime Japan UCITS ETF DR (C) (EUR)

ETF | Others |

Last Closing

USD 26.125

Change

-0.12 (-0.44)%

Market Cap

USD 177.46B

Volume

7.64K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.26 (+0.51%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.11 (+0.71%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.20 (+0.72%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.02 (+0.06%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+0.46 (+0.29%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.28 (+0.65%)

USD 105.55B
8R80:XETRA Amundi Index Solutions - Amund..

+1.40 (+0.99%)

USD 105.05B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.34 (+0.68%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-3.92 (-0.77%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.17 (+0.78%)

USD 79.79B

ETFs Containing PRAJ:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.49% 55% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.49% 55% F 57% F
Trailing 12 Months  
Capital Gain 14.31% 59% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.31% 58% F 61% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.06% 54% F 53% F
Dividend Return 5.06% 53% F 51% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.55% 60% D- 68% D+
Risk Adjusted Return 47.95% 59% D- 62% D
Market Capitalization 177.46B 100% F 98% N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike